Purpose: Sequential PET/CT studies oncology patients can undergo during their treatment follow-up course is limited by radiation dosage. We propose an artificial intelligence (AI) tool to produce attenuation-corrected PET (AC-PET) images from non-attenuation-corrected PET (NAC-PET) images to reduce need for low-dose CT scans.
Methods: A deep learning algorithm based on 2D Pix-2-Pix generative adversarial network (GAN) architecture was developed from paired AC-PET and NAC-PET images. F-DCFPyL PSMA PET-CT studies from 302 prostate cancer patients, split into training, validation, and testing cohorts ( = 183, 60, 59, respectively). Models were trained with two normalization strategies: Standard Uptake Value (SUV)-based and SUV-Nyul-based. Scan-level performance was evaluated by normalized mean square error (NMSE), mean absolute error (MAE), structural similarity index (SSIM), and peak signal-to-noise ratio (PSNR). Lesion-level analysis was performed in regions-of-interest prospectively from nuclear medicine physicians. SUV metrics were evaluated using intraclass correlation coefficient (ICC), repeatability coefficient (RC), and linear mixed-effects modeling.
Results: Median NMSE, MAE, SSIM, and PSNR were 13.26%, 3.59%, 0.891, and 26.82, respectively, in the independent test cohort. ICC for SUV and SUV were 0.88 and 0.89, which indicated a high correlation between original and AI-generated quantitative imaging markers. Lesion location, density (Hounsfield units), and lesion uptake were all shown to impact relative error in generated SUV metrics (all < 0.05).
Conclusion: The Pix-2-Pix GAN model for generating AC-PET demonstrates SUV metrics that highly correlate with original images. AI-generated PET images show clinical potential for reducing the need for CT scans for attenuation correction while preserving quantitative markers and image quality.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075367 | PMC |
http://dx.doi.org/10.18632/oncotarget.28583 | DOI Listing |
Diagnostics (Basel)
December 2024
Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, 2100 Copenhagen, Denmark.
Background/objectives: Brown adipose tissue (BAT) plays a crucial role in energy expenditure and thermoregulation and has thus garnered interest in the context of metabolic diseases. Segmentation in medical imaging is time-consuming and prone to inter- and intra-operator variability. This study aims to develop an automated BAT segmentation method using the nnU-Net deep learning framework, integrated into the TotalSegmentator software, and to evaluate its performance in a large cohort of patients with lymphoma.
View Article and Find Full Text PDFBiomed Phys Eng Express
December 2024
Department of Physics, Faculty of Science University of Guilan, Rasht, Iran.
Attenuation correction of PET data is commonly conducted through the utilization of a secondary imaging technique to produce attenuation maps. The customary approach to attenuation correction, which entails the employment of CT images, necessitates energy conversion. However, the present study introduces a novel deep learning-based method that obviates the requirement for CT images and energy conversion.
View Article and Find Full Text PDFDiagnostics (Basel)
November 2024
Department of Radiology and Nuclear Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
Background: Bleomycin is an oncolytic and antibiotic agent used to treat various human cancers because of its antitumor activity. Unfortunately, up to 46% of the patients treated with bleomycin develop drug-induced interstitial lung disease (DIILD) and potentially life-threatening interstitial pulmonary fibrosis. Tools and biomarkers for predicting and detecting DIILD are limited.
View Article and Find Full Text PDFAm J Nucl Med Mol Imaging
October 2024
Blue Earth Diagnostics Ltd. The Oxford Science Park, Magdalen Centre, Robert Robinson Avenue, Oxford, OX4 4GA, UK.
Background: High-affinity radiohybrid PSMA-targeting radiopharmaceutical F-flotufolastat (F-rhPSMA-7.3) is newly approved for diagnostic imaging of prostate cancer. Here, we conduct a post hoc analysis of two phase 3 studies to quantify F-flotufolastat uptake in a range of normal organs.
View Article and Find Full Text PDFTraffic Inj Prev
November 2024
Center for Injury Research and Prevention, Children's Hospital of Philadelphia, Pennsylvania, Pennsylvania.
Objective: To quantify the head and chest injury metrics associated with a pediatric anthropomorphic test device (ATD) in rearward-facing infant child restraint system (CRS) models positioned directly behind a center console during frontal impact sled tests.
Methods: Sled tests using the Federal Motor Vehicle Safety Standard (FMVSS) 213 frontal crash pulse were performed. The test buck comprised a second row middle seat and center console from the same 2023 model mid-size SUV spaced as per the in-vehicle relative dimensions, a force plate covered with an automotive floor mat, a post-mounted shoulder belt simulating the in-vehicle roof-mounted seatbelt and an array of high-speed cameras.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!